ASGCT Podcast Network
Claim This Podcastby American Society of Gene & Cell Therapy
Podcast Authority
Beta
Podcast Overview
<p>The American Society of Gene & Cell Therapy is the premier membership organization for professionals working in cell and gene therapy. On this network, we're sharing exciting stories from our members and the greater scientific community.</p>
Language
🇺🇲
Publishing Since
10/12/2022
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for ASGCT Podcast Network
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 18, 2026
Setting the Stage: Meet the New Voices Behind The Issue
<p>In this episode of The Issue, new co-hosts Jason West, PhD, and Sanjay D’Souza, PhD, turn the mics on themselves to introduce one another to listeners. Recorded live at the ASGCT 2026 Annual Meeting in Boston, this episode invites listeners to get to know the new co-hosts as they share their backgrounds, ask each other questions, and share how listeners can get involved with future content of The Issue podcast.</p> <p><strong>Music:</strong> ‘Bright New Morning’ by Steven O’Brien – released under CC-BY 4.0. <a href="https://www.steven-obrien.net/">https://www.steven-obrien.net/</a></p><p><a href="https://asgct.org/membership/donate" rel="payment">Show your support for ASGCT!: https://asgct.org/membership/donate</a></p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
June 15, 2026
Member Minutes: Dylan Bechtle
<p>Recorded on site at the ASGCT 2026 Annual Meeting in Boston, this mini-series introduces listeners to ASGCT members and the work driving progress across the cell and gene therapy field. In each episode, members are invited to share their backgrounds, discuss the current state of the field, and reflect on the value of ASGCT membership. This series of brief, engaging conversations will help listeners get to know the people, perspectives, and ideas shaping the ASGCT community.</p> <p>In this episode, host Ben McLeod of the ASGCT Communications Committee talks with Dylan Bechtle, Director of Regulatory Policy in North America at Johnson & Johnson. Dylan shares how ASGCT membership has been valuable to his career in the regulatory space, both through its community and its resources for staying up to date with the CGT field.</p> <p><strong>Music:</strong> 'Origami' by Scott Buckley – released under CC-BY 4.0. <a href="https://url.us.m.mimecastprotect.com/s/IkczCERmXJSyRj4iNfxU7G5vB">www.scottbuckley.com.au</a></p><p><a href="https://asgct.org/membership/donate" rel="payment">Show your support for ASGCT!: https://asgct.org/membership/donate</a></p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
June 4, 2026
Development of a secretable frataxin for Friedrich’s ataxia with Dr. Dan DuBreuil
<p>In this episode, recorded on-site at the ASGCT 2026 Annual Meeting, Molecular Therapy Advances Associate Editor-in-Chief Dr. Dan Stone speaks with Dr. Dan DuBreuil of Sanofi. They break down the science behind a recent paper detailing the development of a secretable frataxin, highlighting its potential to improve treatment efficacy for Friedreich’s ataxia.</p> <p><strong>Music:</strong> 'Electric Dreams' by Scott Buckley - released under CC-BY 4.0. <a href="https://www.scottbuckley.com.au/">www.scottbuckley.com.au</a></p><p><a href="https://asgct.org/membership/donate" rel="payment">Show your support for ASGCT!: https://asgct.org/membership/donate</a></p><p>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.</p>
96 total episodes available
Recent guests on ASGCT Podcast Network
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Dr Kiran Musunuru
Guest
Sheila Mikhail
Guest
Dr Mark Kay
Guest
Thomas Wechsler
Guest
Similar Podcasts
Discover related shows you might enjoy
The Readout Loud
STAT
Biotech Hangout
Daphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler and more
Cell & Gene: The Podcast
Erin Harris
The Long Run with Luke Timmerman
Timmerman Report
BioCentury This Week
BioCentury
Nature Podcast
Springer Nature Limited
Science Magazine Podcast
Science Magazine
Consider This from NPR
NPR
ASCO Daily News
American Society of Clinical Oncology (ASCO)
NEJM This Week
NEJM Group
WSJ Your Money Briefing
The Wall Street Journal
JAMA Editors' Summary
JAMA Network
Money Talks from The Economist
The Economist
HBR On Leadership
Harvard Business Review
Marketplace
Marketplace
Deep-dive analytics for ASGCT Podcast Network
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is ASGCT Podcast Network?
<p>The American Society of Gene & Cell Therapy is the premier membership organization for professionals working in cell and gene therapy. On this network, we're sharing exciting stories from our members and the greater scientific community.</p> - How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.